Kyle Guse
2013
In 2013, Kyle Guse earned a total compensation of $1.3M as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics.
Compensation breakdown
| Non-Equity Incentive Plan | $85,500 |
|---|---|
| Option Awards | $941,716 |
| Salary | $225,000 |
| Total | $1,252,216 |
Guse received $941.7K in option awards, accounting for 75% of the total pay in 2013.
Guse also received $85.5K in non-equity incentive plan and $225K in salary.
Rankings
In 2013, Kyle Guse's compensation ranked 5,667th out of 12,286 executives tracked by ExecPay. In other words, Guse earned more than 53.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,667 out of 12,286 | 54th |
Division Manufacturing | 1,973 out of 4,612 | 57th |
Major group Chemicals And Allied Products | 575 out of 1,466 | 61st |
Industry group Drugs | 411 out of 1,160 | 65th |
Industry Pharmaceutical Preparations | 330 out of 890 | 63rd |
Source: SEC filing on April 11, 2014.
Guse's colleagues
We found two more compensation records of executives who worked with Kyle Guse at Atossa Genetics in 2013.
News
Atossa Genetics CEO Steven Quay's 2022 pay falls 46% to $3.2M
March 30, 2023
Atossa Genetics CEO Steven Quay's 2021 pay jumps 101% to $5.9M
April 11, 2022
Atossa Genetics CEO Steven Quay's 2020 pay falls 49% to $2.9M
April 15, 2021
Atossa Genetics CEO Steven Quay's 2019 pay jumps 209% to $5.8M
April 13, 2020
Atossa Genetics CEO Steven Quay's 2018 pay jumps 84% to $1.9M
April 12, 2019